Drugs / Gan Fu Le Tablets
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03516448 Comparator | Mar → Jun 2016 | hepatocellular carcinoma | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gan Fu Le Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03516448 ↗ |
| Route | Oral | “6 Tablets，tid,po” NCT03516448 ↗ |